标题
The Disease Severity and Clinical Outcomes of the SARS-CoV-2 Variants of Concern
作者
关键词
-
出版物
Frontiers in Public Health
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-12-02
DOI
10.3389/fpubh.2021.775224
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Emergence of a SARS-CoV-2 variant of concern with mutations in spike glycoprotein
- (2021) Houriiyah Tegally et al. NATURE
- SARS-CoV-2 Variant of Concern 202012/01 Has about Twofold Replicative Advantage and Acquires Concerning Mutations
- (2021) Frederic Grabowski et al. Viruses-Basel
- Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study
- (2021) Robert Challen et al. BMJ-British Medical Journal
- SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2
- (2021) Yuyang Lei et al. CIRCULATION RESEARCH
- Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 February
- (2021) Daniel J Grint et al. Eurosurveillance
- Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021
- (2021) Tjede Funk et al. Eurosurveillance
- Mortality risk in patients infected with SARS-CoV-2 of the lineage B.1.1.7 in the UK
- (2021) Chia Siang Kow et al. JOURNAL OF INFECTION
- Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial
- (2021) Katherine R W Emary et al. LANCET
- Lack of detail in population-level data impedes analysis of SARS-CoV-2 variants of concern and clinical outcomes
- (2021) Sean Wei Xiang Ong et al. LANCET INFECTIOUS DISEASES
- Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study
- (2021) Dan Frampton et al. LANCET INFECTIOUS DISEASES
- Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7
- (2021) Nicholas G. Davies et al. NATURE
- Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
- (2021) Shabir A. Madhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil
- (2021) Nuno R. Faria et al. SCIENCE
- Rapid Spread of the SARS-CoV-2 Variant of Concern 202012/01 in Southern Italy (December 2020–March 2021)
- (2021) Daniela Loconsole et al. International Journal of Environmental Research and Public Health
- Alpha variant (B.1.1.7) of SARS-CoV-2 increases fatality-rate for patients under age of 70 years and hospitalization risk overall
- (2021) Meryem Cetin et al. ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA
- Severity of SARS-CoV-2 alpha variant (B.1.1.7) in England
- (2021) Daniel J Grint et al. CLINICAL INFECTIOUS DISEASES
- Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021
- (2021) Finlay Campbell et al. Eurosurveillance
- Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study
- (2021) Peter Bager et al. LANCET INFECTIOUS DISEASES
- The SARS-CoV-2 B.1.1.7 variant and increased clinical severity—the jury is out
- (2021) Benjamin Giles et al. LANCET INFECTIOUS DISEASES
- Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study
- (2021) Martina Patone et al. LANCET INFECTIOUS DISEASES
- Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study
- (2021) Katherine A Twohig et al. LANCET INFECTIOUS DISEASES
- What scientists know about new, fast-spreading coronavirus variants
- (2021) David Adam NATURE
- New variants of SARS-CoV-2
- (2021) Rafael Cantón et al. Revista Espanola de Quimioterapia
- The Alpha Variant (B.1.1.7) of SARS-CoV-2 in Children: First Experience from 3544 Nucleic Acid Amplification Tests in a Cohort of Children in Germany
- (2021) Meike Meyer et al. Viruses-Basel
- Risk of hospital admission for patients with SARS-CoV-2 variant B.1.1.7: cohort analysis
- (2021) Tommy Nyberg et al. BMJ-British Medical Journal
- Emergence and Spread of B.1.1.7 Lineage in Primary Care and Clinical Impact in the Morbi-Mortality among Hospitalized Patients in Madrid, Spain
- (2021) Laura Martínez-García et al. Microorganisms
- SARS-CoV-2 lineage B.1.1.7 is associated with greater disease severity among hospitalised women but not men: multicentre cohort study
- (2021) Oliver Stirrup et al. BMJ Open Respiratory Research
- Review of the early reports of the epidemiological characteristics of the B.1.1.7 variant of SARS-CoV-2 and its spread worldwide
- (2021) Yeonju Kim et al. Osong Public Health and Research Perspectives
- Evaluation of the relative virulence of novel SARS-CoV-2 variants: a retrospective cohort study in Ontario, Canada
- (2021) David N. Fisman et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Clinical outcomes in patients infected with different SARS-CoV-2 variants at one hospital during three phases of the COVID-19 epidemic in Marseille, France
- (2021) Van-Thuan Hoang et al. INFECTION GENETICS AND EVOLUTION
- Trajectories of hospitalisation for patients infected with SARS-CoV-2 variant B.1.1.7 in Norway, December 2020 – April 2021
- (2021) Robert Whittaker et al. JOURNAL OF INFECTION
- Increased risk of hospitalisation and intensive care admission associated with reported cases of SARS-CoV-2 variants B.1.1.7 and B.1.351 in Norway, December 2020 –May 2021
- (2021) Lamprini Veneti et al. PLoS One
- ACE2 and COVID-19 and the resulting ARDS
- (2020) Xiaoqing Zhang et al. POSTGRADUATE MEDICAL JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started